1. Swiss Teratogen Information Service, Service de Pharmacologie Clinique, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland
2. Charité – Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Pharmakovigilanzzentrum Embryonaltoxikologie, Institut für Klinische Pharmakologie und Toxikologie, Berlin, Germany
3. Center for Primary Care and Public Health, University of Lausanne, Lausanne, Switzerland
4. Department of Woman-Mother-Child, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland
5. Materno-Fetal and Obstetrics Research Unit, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland
6. Department of Clinical Neurosciences, Division of Neurology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland
7. The Israeli Teratology Information Service, Ministry of Health, Jerusalem, Israel/The Hebrew University Hadassah Medical School, Jerusalem, Israel
8. Centre Régional de Pharmacovigilance, Hospices Civils de Lyon, Lyon, France
9. Clinical Pharmacology Service, Vall d’Hebron University Hospital, Barcelona, Spain
10. Division of Clinical Pharmacology and Toxicology, Geneva University Hospitals, Geneva, Switzerland
11. Terafar – Izmir Katip Celebi University Teratology Information, Research and Training Center, Izmir, Turkey
12. Mothersafe, The Royal Hospital for Women, Sydney, NSW, Australia/School of Women’s and Children’s Health, University of New South Wales, Sydney, NSW, Australia
13. Department of Pharmacology, Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkey
14. School of Pharmaceutical Sciences, University of Geneva and University of Lausanne, Geneva, Switzerland